CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 8.26: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.69BCNY550.57M · vs all stocks (USD)
Trailing P/E
106.21xvs Medical Devices peers
Revenue (TTM)
371.61MCNY55.49M · vs all stocks (USD)
Profit Margin
8.84%vs Medical Devices peers
Beta
0.7160xvs all stocks
52-Week Change
35.35%vs all stocks
Market Capitalization
3.69BCNY550.57M · vs all stocks (USD)
Enterprise Value
3.66BCNY547.10M · vs all stocks (USD)
Trailing P/E
106.21xvs Medical Devices peers
Forward P/E
43.79xvs Medical Devices peers
Price to Sales (TTM)
9.33xvs Medical Devices peers
Price to Book (MRQ)
3.12xvs Medical Devices peers
Enterprise to Revenue
9.86xvs Medical Devices peers
Enterprise to EBITDA
78.06xvs Medical Devices peers
Gross Margin
39.68%vs Medical Devices peers
Profit Margin
8.84%vs Medical Devices peers
Operating Margin
5.12%vs Medical Devices peers
Return on Assets (TTM)
0.87%vs Medical Devices peers
Return on Equity (TTM)
2.50%vs Medical Devices peers
Revenue (TTM)
371.61MCNY55.49M · vs all stocks (USD)
Revenue per Share (TTM)
2.62CNYUpdated Sep 22, 2026Quarterly Revenue Growth
33.30%vs Medical Devices peers
Gross Profit (TTM)
148.32MCNY22.15M · vs all stocks (USD)
EBITDA (TTM)
84.24MCNY12.58M · vs all stocks (USD)
Net Income (TTM)
32.86MCNY4.91M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
130.70%vs Medical Devices peers
Operating Cash Flow (TTM)
27.09MCNY4.04M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-4.73MCNY-707.02K · vs all stocks (USD)
Payout Ratio
0.00%vs Medical Devices peers
Minority Interest (Equity)
83.28MCNYFY2025 · Dec 31, 2025Revenue
345.49MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
194.58MCNYFY2025 · Dec 31, 2025Gross Profit
150.90MCNYFY2025 · Dec 31, 2025Operating Income
58.21MCNY8.69M · vs all stocks (USD)
Pre-tax Income
31.53MCNYFY2025 · Dec 31, 2025Income Tax Expense
5.80MCNYFY2025 · Dec 31, 2025Net Income
25.73MCNYFY2025 · Dec 31, 2025EBIT
35.51MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
84.24MCNYFY2025 · Dec 31, 2025Research & Development
21.73MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
25.48MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.13MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
255.05KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
3.99MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
133.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
133.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
25.73MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
5.05MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
39.07MCNYFY2025 · Dec 31, 2025Free Cash Flow
14.60MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
185.69MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
25.73MCNYFY2025 · Dec 31, 2025Other Non-cash Items
5.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
5.30MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
2.24MCNYFY2025 · Dec 31, 2025Capital Expenditures
-24.47MCNYFY2025 · Dec 31, 2025Purchase of Investments
-3.36MCNYFY2025 · Dec 31, 2025Sale of Investments
61.85KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-27.77MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
163.10MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-164.25MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-3.99MCNYFY2025 · Dec 31, 2025Other Financing Charges
-100.00KCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-5.24MCNYFY2025 · Dec 31, 2025Shares Outstanding
136.00MSharesUpdated Sep 22, 2026Float Shares
67.65MSharesUpdated Sep 22, 2026% Held by Insiders
47.11%vs all stocks
% Held by Institutions
1.06%vs all stocks
Total Cash (MRQ)
70.55MCNY10.54M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.5190CNYUpdated Sep 22, 2026Total Debt (MRQ)
163.46MCNY24.41M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1346xvs Medical Devices peers
Current Ratio (MRQ)
2.57xvs Medical Devices peers
Book Value per Share (MRQ)
8.16CNYUpdated Sep 22, 2026Total Assets
1.50BCNY223.91M · vs all stocks (USD)
Total Current Assets
757.15MCNYFY2025 · Dec 31, 2025Total Liabilities
313.25MCNYFY2025 · Dec 31, 2025Total Non-current Assets
742.31MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
3.86MCNYFY2025 · Dec 31, 2025Total Current Liabilities
309.39MCNYFY2025 · Dec 31, 2025Cash
185.69MCNYFY2025 · Dec 31, 2025Cash Equivalents
533.82KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
186.22MCNYFY2025 · Dec 31, 2025Accounts Receivable
401.04MCNYFY2025 · Dec 31, 2025Inventory
92.11MCNYFY2025 · Dec 31, 2025Accounts Payable
102.46MCNYFY2025 · Dec 31, 2025Short-term Debt
125.10MCNYFY2025 · Dec 31, 2025Other Current Liabilities
13.73MCNYFY2025 · Dec 31, 2025Common Stock (Book)
136.00MCNYFY2025 · Dec 31, 2025Retained Earnings
568.63MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.19BCNY177.14M · vs all stocks (USD)
52-Week Low
18.15CNYUpdated Sep 22, 202652-Week High
36.58CNYUpdated Sep 22, 202652-Week Change
35.35%vs all stocks
Beta
0.7160xvs all stocks
50-Day MA
25.92CNYUpdated Sep 22, 2026200-Day MA
23.94CNYUpdated Sep 22, 2026Avg 10-Day Volume
1.36MSharesUpdated Sep 22, 2026Avg 30-Day Volume
1.92MSharesUpdated Sep 22, 2026Diluted EPS (TTM)
0.2400CNYUpdated Sep 22, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 8.26: safe zoneNotable
Altman Z-Score: 8.26
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Guangdong Transtek Medical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Zhuhai Rundu Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
TaiMed Biologics Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Lifecome Biochemistry Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Nanjing Hicin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Delcath Systems Inc.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Gujarat Themis Biosyn Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Pharmicell Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Shanghai Shen Lian Bio-Medicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Companies that share active interpretations — structural patterns currently present in both stocks.
Cec Environmental Protection Co. Ltd.
1 interpretationHigh Retained Earnings With Profitability And Equity
Qingdao Eastsoft Communication Co., Ltd.
1 interpretationHigh Retained Earnings With Profitability And Equity
Edan Instruments Inc.
1 interpretationHigh Retained Earnings With Profitability And Equity